Clinical Trial Update: Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating local administration of DepoTXA to reduce postsurgical bleeding in total knee arthroplasty; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Knee Arthroplasty

Drugs mentioned

• DepoTXA (tranexamic acid formulation)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Total Knee Arthroplasty | Phase 2 | Status: TERMINATED | Results posted: 2020-12-11